Prior Auth Required

10591 - 6 Veopoz prescribing information, Regeneron Pharmaceuticals, Inc., Tarrytown, NY . Revised 3/24 8/25

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Service6 Veopoz prescribing information, Regeneron Pharmaceuticals, Inc., Tarrytown, NY . Revised 3/24 8/25
Procedure / Service Description

Pharmacy Policy - events-human-drugs/fda-approves-first-treatment-cd55-deficient-protein-losing-enteropathy-chaple- disease 6 Veopoz prescribing information, Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591. Revised 3/24 8/25 3/2024. 7 Ozen A, et al. Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease. Nat 2/24 8/23

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.